AstraZeneca Running Nexium DTC Sampling Program Via AdvancePCS
Executive Summary
AstraZeneca is running a direct-to-consumer sampling coupon program for the anti-ulcer drug Nexium (esomeprazole).
You may also be interested in...
AstraZeneca Crestor Copromotion Decision Coming: Nexium Has 6% Share
AstraZeneca expects to make a decision on whether to use a copromotion partner for the HMG-CoA reductase inhibitor Crestor (rosuvastatin) within "the next six to eight weeks," CFO Jonathan Symonds told the Goldman Sachs healthcare conference June 12 in Dana Point, Calif.
AstraZeneca Crestor Copromotion Decision Coming: Nexium Has 6% Share
AstraZeneca expects to make a decision on whether to use a copromotion partner for the HMG-CoA reductase inhibitor Crestor (rosuvastatin) within "the next six to eight weeks," CFO Jonathan Symonds told the Goldman Sachs healthcare conference June 12 in Dana Point, Calif.
AstraZeneca Nexium Relying On Healing Rate, Symptom Maintenance
AstraZeneca's efforts to build a superiority claim for the proton pump inhibitor Nexium hinge on three elements of labeling.